Concentrix Writes Off $1.05 Billion of Goodwill Against Its Own Share Price, Beats on Margin and Cuts Full-Year Revenue Guidance to a Constant-Currency Decline

by Priya Raghunathan · September 30, 2026

Mid-Cap Companies Reporter, The SmallCap Signal

Concentrix reported a third-quarter net loss of $988.1 million, or $16.24 a diluted share, after taking a $1,050.0 million non-cash goodwill impairment that the company attributes "primarily" to "the trading range for the Company's stock price and market capitalization," according to its results release dated Sept. 29 and furnished with a Form 8-K. Revenue for the quarter ended Aug. 31 was $2,453.7 million, down 1.2% as reported and down 0.5% in constant currency from $2,483.3 million a year earlier.

The revenue figure landed below the range the company set three months ago. In its June 29 second-quarter release, Concentrix guided third-quarter revenue to $2.465 billion to $2.490 billion, implying constant-currency growth of 0.0% to 1.0%. The actual constant-currency result was a 0.5% decline. Non-GAAP operating income of $309.0 million, by contrast, cleared the $295 million to $305 million range, and non-GAAP diluted EPS of $2.92 beat the $2.65 to $2.77 guidance, the company's own figures show.

That split, softer top line and firmer margin, is the shape of the whole report. Non-GAAP operating margin rose 30 basis points to 12.6%, adjusted EBITDA rose 1.1% to $363.0 million at a 14.8% margin, and non-GAAP net income rose 1.8% to $186.5 million. Cash flow from operations was $268.2 million, which the company called a third-quarter record, and adjusted free cash flow, which strips out changes in its receivables factoring balance, was $218.3 million against $178.8 million a year earlier.

The impairment is the number that reorders the balance sheet. Goodwill fell to $2,636.7 million at Aug. 31 from $3,671.7 million at Nov. 30, 2025, and total assets fell to $9.26 billion from $10.76 billion, according to the condensed balance sheet in the release. Because the charge is non-cash and excluded from the company's non-GAAP measures, it does not touch the adjusted margins or the cash flow figures; what it does is record, in the company's own accounting, that the market has been valuing the business below the carrying value of acquisitions it made in past years.

Chief executive Chris Caldwell chose to describe the quarter as a transition in the revenue base rather than a slowdown. "This quarter, we reached an inflection point where 50% of our revenue is coming from business we have won and deployed within the last 3 years since the introduction of AI," he said in the release. "While we are aggressively disrupting our own traditional business, the underlying new business is stronger and healthier as evidenced by our margin expansion, strong free cash flow and growth of our new services."

The vertical table in the release shows where the pressure sits. Technology and consumer electronics revenue fell 10% to $603.5 million, communications and media fell 7% to $381.9 million and healthcare fell 17% to $145.2 million. Retail, travel and e-commerce rose 6% to $662.6 million and banking, financial services and insurance rose 12% to $432.5 million. For the nine months, total revenue was $7,416.5 million, up 2% from $7,272.8 million.

Guidance is where the quarter turns more cautious. For the fiscal fourth quarter ending Nov. 30, Concentrix expects reported revenue of $2.410 billion to $2.460 billion, which it says "implies constant currency revenue decline for the quarter ranging from (5.0)% to (3.0)%," after an assumed 65-basis-point currency headwind. It expects GAAP operating income of $174 million to $184 million, non-GAAP operating income of $310 million to $320 million and non-GAAP diluted EPS of $2.86 to $2.98 on about 61.2 million diluted shares.

The full-year revenue range came down. Concentrix now guides fiscal 2026 revenue to $9.827 billion to $9.877 billion, implying a constant-currency decline of 0.8% to 0.3%. On June 29 the range was $9.925 billion to $10.025 billion, implying constant-currency growth of 0.25% to 1.25%. At the low end the cut is $98 million and at the high end $148 million; those differences are our arithmetic from the two ranges. Because the impairment lands in GAAP operating income, the full-year GAAP outlook flipped from operating income of $509 million to $539 million in June to an operating loss of $512 million to $522 million now.

The profit ranges moved less. Full-year non-GAAP operating income is now $1,206 million to $1,216 million, inside the earlier $1,200 million to $1,230 million range, and non-GAAP EPS is $10.97 to $11.09 against the earlier $10.83 to $11.18, so the midpoint edged up while the top end came down. The adjusted free cash flow target of $630.0 million to $650.0 million is unchanged. The expected effective tax rate moved to approximately 24% from approximately 24.5%.

Concentrix, based in Newark, Calif., describes itself in the release as a technology and services company that designs, builds and runs "integrated human and AI solutions" for more than 2,000 client organizations, a business built substantially through acquisitions that left it carrying $3.67 billion of goodwill and $1.96 billion of intangible assets at the start of the fiscal year. Amortization of intangibles ran $100.9 million in the quarter and $306.4 million over nine months, per the non-GAAP reconciliation, and it remains the biggest bridge between GAAP and adjusted profit after the impairment.

The balance sheet also shows a business in the middle of a disposal. Assets held for sale of $213.0 million and liabilities held for sale of $182.1 million sit on the Aug. 31 balance sheet where there were none at Nov. 30 (the line first appeared at May 31, at $202.7 million and $172.3 million, in the June 29 release), and the reconciliation tables carry a loss on held-for-sale of $1.5 million for the quarter and $8.4 million for nine months. The release does not identify the business being sold. Cash was $244.7 million, down from $327.3 million, while long-term debt fell to $3,925.4 million from $4,572.9 million and the current portion of debt rose to $450.0 million from $65.6 million, indicating a maturity now inside twelve months.

Capital returns tilted to the dividend. The board raised the quarterly payout to $0.37 a share from $0.36, payable Nov. 3 to holders of record Oct. 23. The company repurchased no shares in the quarter and had $396.6 million of authorization left at Aug. 31, so the impairment that it ties to its own share price coincided with a quarter in which it did not buy any of that stock.

The release does not say what the impairment test assumed about future cash flows, which reporting unit carried the charge, or whether further testing is expected in the fourth quarter; those details typically appear in the 10-Q, which had not been filed as of this writing. It also does not reconcile the non-GAAP EPS or adjusted free cash flow outlook to GAAP, saying it cannot do so without unreasonable effort because of currency movements and the timing of factoring changes.

What to watch is whether the fourth-quarter constant-currency decline of 3% to 5% is the trough Caldwell's "inflection point" language implies or the start of a steeper reset as legacy contracts roll off. The company held its earnings call at 5:00 p.m. ET on Sept. 29; the 10-Q for the quarter and the identity of the held-for-sale business are the next disclosures to check.